期刊
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
卷 14, 期 7, 页码 936-946出版社
BENTHAM SCIENCE PUBL
DOI: 10.2174/1871527314666150317230124
关键词
Aging; cancer; non-coding RNA; telomerase; telomere
资金
- CSIR-EpiHeD-Network Scheme [BSC0118]
- Science & Engineering Research Board [SR/FT/LS-80/2011]
- Department of Biotechnology-Twinning Programme, New Delhi, India [BCIL/NER-BPMC/2013/722]
- Council of Scientific and Industrial Research (CSIR), Government of India, India
Telomeric repeat containing RNAs (TERRA) are small RNA molecules synthesized from telomeric regions which were previously considered as silent genomic domains. In normal cells, these RNAs are transcribed in a direction from subtelomeric region towards the chromosome ends, but in case of cancer cells, their expression remains limited or absent. Telomerase is a rate limiting enzyme for cellular senescence, cancer and aging. Most of the studies deal with the manipulation of telomerase enzyme in cancer and aging either by synthetic oligonucleotide or by natural phytochemicals. Here, we collected evidences and discussed intensely about the bio-molecular structure of TERRA, naturally occurring ligands of telomerase, and their genetic and epigenetic regulations in aging associated diseases. Due to their capability to act as naturally occurring ligands of telomerase, these RNAs can overcome the limitations possessed by synthetic oligonucleotides, which are aimed against telomerase. Drugs specifically targeting TERRA molecules could modulate telomerase-mediated telomere lengthening. Thus, targeting TERRA-mediated regulation of telomerase would be a promising therapeutic strategy against cancer and age-associated diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据